ArticleCell reports. Medicine2025

Interferon-responsive HEVs drive tumor tertiary lymphoid structure formation and predict immunotherapy response in nasopharyngeal carcinoma.

Shang-Xin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.